Rx
🏭 Dr. Reddy's
⚗️ Made by Dr. Reddy's
❄️ Cold Chain
🛡️ 13-Valent (PCV13-TT)
🇮🇳 Made in India
Pneumoguard-13 · Dr. Reddy's Ltd · 0.5 mL Single Dose PFS with 25G 1" Needle · Intramuscular · Shake Well Before Use
13 Serotypes · CRM197 Carrier 20–50 µg · Al-Phosphate ≤0.75mg · Store 2–8°C · Do Not Freeze · Dr. Reddy's Ltd
⚖️ Pneumoguard-13 vs Other Available PCVs – At a Glance
⭐ This Page
14
Pneumoguard-13
Dr. Reddy's Laboratories Ltd.
CRM197 carrier
Al-phosphate ≤0.75mg
CRM197 carrier
Al-phosphate ≤0.75mg
+ Serotypes 22F & 33F
Not in PCV13
Not in PCV13
Standard
13
Prevenar 13
Pfizer (imported)
CRM197 carrier
Al-phosphate 0.125mg
CRM197 carrier
Al-phosphate 0.125mg
Includes serotype 6A
Global gold standard
Global gold standard
Affordable
10
Pneumosil PFS
Serum Institute (SII)
CRM197 carrier
WHO PQ 2020
CRM197 carrier
WHO PQ 2020
Includes 6A & 19A
Most affordable
Most affordable
💡 The 22F & 33F Advantage: Pneumoguard-13 uniquely covers serotypes 22F and 33F — emerging serotypes that are increasingly contributing to Invasive Pneumococcal Disease (IPD) in India and globally as herd immunity from PCV13 reduces other serotypes. These are absent in ALL other PCVs currently available in India.
🛡️ Pneumococcal Diseases Pneumoguard-13 Protects Against
Pneumococcal Pneumonia
Streptococcus pneumoniae is the #1 bacterial cause of pneumonia in children and adults. Pneumoguard-13's 13 Serotypes cover the widest range of disease-causing strains, including emerging ones (22F, 33F).
Bacterial Meningitis
Pneumococcal meningitis — 20–30% fatality rate, 30–50% survivors with permanent disabilities. Multiple Pneumoguard-13 serotypes (1, 3, 6B, 14, 19A, 23F) are major meningitis-causing strains.
Septicaemia / Bacteraemia
Invasive pneumococcal bloodstream infection — high mortality in young infants and elderly. Serotypes 1, 3, 4, 14, 18C, 19F are common causes of invasive disease — all covered by Pneumoguard-13.
Acute Otitis Media & Sinusitis
Pneumococcus causes most bacterial ear infections in children — the #1 reason for antibiotic prescriptions. Pneumoguard-13's extra serotypes (22F, 33F) also contribute to AOM, making protection more comprehensive.
🌍 Serotype Replacement: As PCV13 has reduced disease from its 13 serotypes globally, serotypes NOT in PCV13 (like 22F and 33F) are becoming more prevalent. Pneumoguard-13's additional coverage directly addresses this emerging public health challenge.
👥 Who Should Get Pneumoguard-13?
All Infants from 6 Weeks ⭐
Primary target: all infants from 6 weeks of age. PCV vaccination is IAP 2024 recommended routine infant immunisation. Pneumoguard-13 provides the broadest available serotype coverage.
Premature & High-Risk Infants
Preterm babies, low birth weight, congenital heart disease, chronic lung disease — all face higher risk from invasive pneumococcal disease. PCV13-TT's broader coverage is especially valuable here.
Immunocompromised Children
HIV-positive, asplenic, on chemotherapy or immunosuppressants — at high risk for IPD from any serotype including emerging 22F/33F. Pneumoguard-13 is inactivated — safe for all these groups.
Adults 65+ (Catch-Up)
Elderly adults with chronic diseases (COPD, heart disease, diabetes, kidney disease) at high risk for pneumococcal pneumonia. Pneumoguard-13's 22F/33F coverage adds meaningful extra protection.
Already Vaccinated with PCV13?
Children and adults previously vaccinated with Prevenar 13 may discuss with their doctor whether additional PCV13-TT doses could provide 22F/33F coverage — especially immunocompromised individuals.
Families Wanting Maximum Coverage
Parents who want the broadest possible serotype protection for their child — particularly relevant as serotype replacement increases the importance of 22F and 33F coverage.
🔬 Pneumoguard-13 Composition – Per 0.5 mL Dose
As per Dr. Reddy's Laboratories Ltd. manufacturer label. Each 0.5 mL PFS contains:
| Component | Quantity | Notes |
|---|---|---|
| SEROTYPE 1 (Unique Dose) | ||
| Pneumococcal Polysaccharide serotype 1 | 3.0 µg | Higher dose than standard serotypes |
| SEROTYPES 3, 4, 5, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F (Standard Dose) | ||
| Pneumococcal Polysaccharide serotypes 3, 4, 5, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F | 2.2 µg each | 12 serotypes at standard dose |
| SEROTYPE 6B (Higher Dose) | ||
| Pneumococcal Polysaccharide serotype 6B | 4.4 µg | Double the standard dose — 6B requires higher antigen content |
| CARRIER PROTEIN & ADJUVANT | ||
| TT carrier protein | 20 to 50 µg | Non-toxic diphtheria toxin mutant — same carrier as Prevenar 13. Each polysaccharide individually conjugated. |
| Aluminium (as Aluminium Phosphate) | ≤ 0.75 mg Al+++ | Adjuvant — enhances and prolongs immune response |
💡 CRM197 — Same as Prevenar 13: Pneumoguard-13 uses the same CRM197 (non-toxic diphtheria toxin mutant) carrier protein as Pfizer's Prevenar 13. Each of the 14 polysaccharides is individually conjugated to CRM197, generating T-cell-dependent immunity, immunological memory, and effective protection from 6 weeks of age.
⚠️ Store between 2°C to 8°C. Do not freeze. Shake well before use. Supplied with one separate 25 Gauge 1" needle. Please refer to the needle pack for batch number and expiry date of needle. VacciHub nurses follow all storage and administration protocols.
📅 Pneumoguard-13 – IAP 2024 Vaccination Schedule
| Schedule | Dose | Age | Notes |
|---|---|---|---|
| 3+1 SCHEDULE (Standard) | |||
| 3+1 | Dose 1 | 6 weeks | Earliest recommended age |
| Dose 2 | 10 weeks | Minimum 4 weeks from Dose 1 | |
| Dose 3 | 14 weeks | Minimum 4 weeks from Dose 2 | |
| Booster | 12–15 months | ⭐ Critical — restores waning immunity | |
| 2+1 SCHEDULE (Alternative) | |||
| 2+1 | Dose 1 | 2 months | Min 8 weeks between doses |
| Dose 2 | 4 months | 2 months after Dose 1 | |
| Booster | 12 months | ⭐ Min 6 months after Dose 2 | |
ℹ️ Catch-up vaccination: Children who missed the primary PCV series can receive catch-up doses up to 5 years of age. Schedule depends on current age. Call VacciHub for a personalised catch-up plan. Adults 65+ with chronic conditions receive a single dose.
⚠️ The booster at 12–15 months is critical — antibody levels from the primary series wane significantly by 12 months. The booster triggers a powerful memory response. VacciHub sends WhatsApp reminders for all PCV doses.
⚙️ How Does Pneumoguard-13 Work?
1
14 Polysaccharide–CRM197 Conjugates Injected IM
After shaking well, 0.5 mL is injected intramuscularly (anterolateral thigh in infants, deltoid in older children/adults). The dose delivers 14 individual pneumococcal polysaccharide–CRM197 conjugates adsorbed on aluminium phosphate adjuvant.
2
CRM197 Recruits T-Helper Cells (T-Dependent Immunity)
The CRM197 carrier protein activates CD4+ T-helper cells for each of the 14 conjugates simultaneously. This generates T-cell-dependent immune responses — creating true immunological memory, effective from 6 weeks, and an amplified booster response on subsequent doses.
3
14 Serotype-Specific IgG Antibodies Produced
The immune system generates protective IgG antibodies against all 13 Pneumococcal Serotypes including 22F and 33F — the emerging strains. These antibodies bind pneumococcal bacteria, activate complement and facilitate opsonophagocytic killing, preventing invasive disease.
4
Herd Protection + Nasopharyngeal Carriage Reduction
PCV vaccination reduces pneumococcal nasopharyngeal colonisation — the source of spread. Vaccinated children are less likely to carry and transmit pneumococcus to unvaccinated contacts (elderly, immunocompromised), creating indirect herd protection.
⚠️ Pneumoguard-13 Side Effects
Pneumoguard-13 has a well-established safety profile similar to other CRM197-conjugated PCVs.
🟡 Common (Mild, 1–3 Days)
- 💉 Injection-site pain / tenderness
- 🔴 Redness or swelling at site
- 🌡️ Low-grade fever (<38.5°C)
- 😢 Irritability / crying (infants)
- 😴 Drowsiness / poor appetite
🔴 Rare – Seek Medical Attention
- 🤒 High fever (>39°C)
- 😢 Prolonged crying >3 hours
- ⚡ Febrile seizure (rare)
- 🚨 Anaphylaxis (extremely rare)
💡 Apply a cool cloth to the injection site. Paracetamol as per your paediatrician's advice. Our VacciHub nurses observe babies for 30 minutes post-vaccination and advise on fever management before leaving.
⚖️ Pneumoguard-13 (PCV13-TT) vs Prevenar 13 (PCV13) – Detailed Comparison
| Feature | Pneumoguard-13 (PCV13-TT) | Prevenar 13 (PCV13) |
|---|---|---|
| Marketed by | ✓ Dr. Reddy's (Indian brand) | Pfizer (imported) |
| Manufactured by | ✓ Dr. Reddy's, Hyderabad | Pfizer, Belgium |
| Serotypes covered | ✓ 14 | 13 |
| Carrier protein | ✓ CRM197 (same as PCV13) | ✓ CRM197 |
| Serotype 22F | ✓ Included (2.2 µg) | ✗ Not included |
| Serotype 33F | ✓ Included (2.2 µg) | ✗ Not included |
| Serotype 3 | ✓ Included (2.2 µg) | ✓ Included |
| Serotype 6A | ✗ Not explicitly listed | ✓ Included |
| Serotype 19A | ✓ Included | ✓ Included |
| Al-Phosphate adjuvant | ≤ 0.75 mg | 0.125 mg |
| Needle included | ✓ 25G 1" needle in pack | Varies by pack |
| Made in India | ✓ Yes – Hyderabad | No – imported |
| IAP recommendation | ✓ Accepted | ✓ Standard |
✅ Key advantage of Pneumoguard-13: The additional serotypes 22F and 33F are increasingly important as PCV13 immunisation drives serotype replacement — strains not covered by PCV13 are emerging as relatively more prevalent in IPD. Pneumoguard-13 is the only PCV in India proactively addressing this with 13-Valent coverage.
🚫 Precautions & Contraindications
Do NOT give Pneumoguard-13 if:
- Known hypersensitivity to any component including CRM197 or aluminium phosphate
- Severe allergic reaction to a prior PCV dose
- Acute moderate-to-severe febrile illness — defer until recovery
Use with Caution:
- Immunosuppressed patients — immune response may be reduced; PCV still strongly recommended
- Coagulation disorders — use fine needle, firm pressure post-injection
- Do NOT mix with other vaccines in the same syringe
- IM administration only — not IV or intradermal
⚠️ Do NOT freeze. Shake well before use. Needle details (batch/expiry) are on the needle pack — verify before use. VacciHub nurses check all these details before every injection. The included 25G 1" needle is appropriate for deltoid/anterolateral thigh IM administration.
🏥 Why Book Pneumoguard-13 with VacciHub?
Certified Paediatric Nurses
Trained nurses experienced in infant and adult vaccination. Correct IM injection technique. Pre-vaccination health check and 30-minute post-vaccination observation included.
Cold Chain — Never Frozen
Pneumoguard-13 must NEVER be frozen. Our validated cold boxes maintain 2–8°C throughout. Temperature verified before every dose administration.
Genuine Dr. Reddy's
Sourced from authorised Dr. Reddy's distributors only. Batch numbers and needle pack details fully verified and shared on your WhatsApp vaccination record.
Home Comfort
No hospital queues, no infection-risk waiting rooms. Your baby stays calm and safe at home. Especially convenient for infants and families with multiple children.
Full Series + Booster Tracking
We track all 3 primary doses AND the 12–15 month booster, sending WhatsApp reminders for each. Never miss a dose in the PCV series.
Flexible & Same-Day Slots
Morning to evening, weekends included. Multiple vaccines administered in the same visit at different sites — minimising total home visit trips.
📍 Pneumoguard-13 Home Vaccination – Cities We Cover
🏛️Delhi (All Areas)
🏙️Gurgaon
🌆Noida
🏘️Ghaziabad
🏗️Faridabad
🌇Greater Noida
Call +91 92050 04114 to confirm your area — same-day slots available.
❓ Frequently Asked Questions – Pneumoguard-13
Pneumoguard-13 is a 13-Valent Pneumococcal Conjugate Vaccine (PCV13-TT) manufactured and marketed by Dr. Reddy's Laboratories Ltd., Hyderabad. It covers 13 Pneumococcal Serotypes — all 13 from Prevenar 13 PLUS serotypes 22F and 33F. These two extra serotypes are emerging causes of Invasive Pneumococcal Disease (IPD) as serotype replacement occurs in countries using PCV13. Pneumoguard-13 is the broadest PCV available in India.
Pneumoguard-13 contains: Serotype 1 (3.0 µg), Serotypes 3, 4, 5, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F (2.2 µg each), and Serotype 6B (4.4 µg). All are individually conjugated to CRM197 carrier protein (20–50 µg total) and adsorbed on Aluminium Phosphate (≤0.75 mg Al+++).
3+1 (standard): Dose 1 at 6 weeks, Dose 2 at 10 weeks, Dose 3 at 14 weeks, Booster at 12–15 months.
2+1 (alternative): Dose 1 at 2 months, Dose 2 at 4 months, Booster at 12 months.
The booster is critical — antibodies wane after the primary series and the booster restores high-level memory immunity. VacciHub tracks and reminds for all 4 doses.
2+1 (alternative): Dose 1 at 2 months, Dose 2 at 4 months, Booster at 12 months.
The booster is critical — antibodies wane after the primary series and the booster restores high-level memory immunity. VacciHub tracks and reminds for all 4 doses.
Pneumoguard-13 is manufactured by Dr. Reddy's Laboratories Ltd., Plot No. 1, Biotech Park, Phase II, Kolthur Village, Shameerpet, Medchal-Malkajgiri District, Hyderabad – 500078, Telangana, India (Mfg. Lic. No.: 01/RR/AP/2006/V/R). It is marketed by Dr. Reddy's Laboratories Ltd., Bhiwandi, Maharashtra. A trademark of Dr. Reddy's Laboratories Ltd.
Yes. VacciHub provides home vaccination with genuine Pneumoguard-13 across Delhi, Gurgaon, Noida, Ghaziabad, Faridabad and Greater Noida. Our certified nurses shake the syringe well, use the included 25G needle for correct IM injection, and follow post-vaccination monitoring. Call +91 92050 04114 or WhatsApp to book.
As widespread use of PCV13 has dramatically reduced disease from its 13 serotypes, serotype replacement has occurred globally — serotypes NOT in PCV13 (especially 22F and 33F) are contributing proportionally more to invasive pneumococcal disease. Studies from Europe, the USA and Asia show 22F is becoming one of the most common IPD serotypes. Pneumoguard-13 proactively covers these emerging serotypes, providing future-proof protection.
Common side effects are mild: injection-site pain, redness, swelling, low-grade fever, irritability and drowsiness in infants — resolving in 1–3 days. These are typical for aluminium-adjuvanted conjugate vaccines. Paracetamol may be given for fever/pain per your paediatrician's advice. Serious adverse events are very rare. Our VacciHub nurses observe babies for 30 minutes post-vaccination.